journal cover

Role of imaging biomarkers for prognostic prediction in patients with pancreatic ductal adenocarcinoma

Clinical Radiology

Feb 11, 2020

S-J CuiX-Y Gong

Download from

Publisher
PubMed

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive tumours. PDAC has a poor prognosis; therefore, it is necessary to perform further risk stratification. Identifying prognostic factors before treatment might help to implement suitable and personalised treatment for in...read more

Mentioned in this Paper

Local
Adverse Effects
Imaging Techniques
Prognosis Bad
Diagnostic Imaging
Oncologist
Prognostic Factor
Neoplasms
Stratification
Biological Markers
Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Feeds With Similar Papers

Pancreatic Adenocarcinoma

Pancreatic adenocarcinoma holds a significant mortality risk, largely due to its late diagnosis and ineffective chemotherapeutic response. This gastrointestinal malignancy offers a poor prognosis and the only potential cure is through surgical resection. Here are the latest discoveries pertaining to this disease.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research

Tissue biomarkers for prognosis in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis

Clinical Cancer Research : an Official Journal of the American Association for Cancer ResearchMarch 30, 2011
Nigel B JamiesonKarin A Oien
The Lancet. Gastroenterology & Hepatology

Molecular radionuclide imaging of pancreatic neoplasms

The Lancet. Gastroenterology & HepatologyJune 7, 2019
Ananya PandaAjit H Goenka
© 2020 Meta ULC. All rights reserved

Role of imaging biomarkers for prognostic prediction in patients with pancreatic ductal adenocarcinoma

Clinical Radiology

Feb 11, 2020

S-J CuiX-Y Gong

PMID: 32037002

DOI: 10.1016/j.crad.2019.12.023

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive tumours. PDAC has a poor prognosis; therefore, it is necessary to perform further risk stratification. Identifying prognostic factors before treatment might help to implement suitable and personalised treatment for in...read more

Mentioned in this Paper

Local
Adverse Effects
Imaging Techniques
Prognosis Bad
Diagnostic Imaging
Oncologist
Prognostic Factor
Neoplasms
Stratification
Biological Markers

Feeds With Similar Papers

Pancreatic Adenocarcinoma

Pancreatic adenocarcinoma holds a significant mortality risk, largely due to its late diagnosis and ineffective chemotherapeutic response. This gastrointestinal malignancy offers a poor prognosis and the only potential cure is through surgical resection. Here are the latest discoveries pertaining to this disease.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research

Tissue biomarkers for prognosis in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis

Clinical Cancer Research : an Official Journal of the American Association for Cancer ResearchMarch 30, 2011
Nigel B JamiesonKarin A Oien
The Lancet. Gastroenterology & Hepatology

Molecular radionuclide imaging of pancreatic neoplasms

The Lancet. Gastroenterology & HepatologyJune 7, 2019
Ananya PandaAjit H Goenka
Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Download from

Publisher
PubMed
/papers/role-of-imaging-biomarkers-for-prognostic/32037002